Neoantigen Targeted Therapies Market Growth and Trends: Key Insights into Market Opportunities for 2025-2034
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
How Are Key Drivers Contributing to the Growth and Expansion of the Neoantigen Targeted Therapies Market?
The rise in cancer occurrences is anticipated to fuel the expansion of the neoantigen targeted therapies market in the future. The term cancer incidence is used to describe the rate of new cancer cases within a certain demographic over a specified timeframe. Neoantigen-targeted treatments are typically combined to address various types of cancer. For example, in 2022 the American Cancer Society (ACS), an American voluntary health institution, shared that the United States saw a drastic rise in new cancer cases with 1.9 million reported incidences, a considerable surge compared to past years. Moreover, approximately 609,360 cancer-related deaths were recorded in the US in 2022, highlighting the profound effect and seriousness of this illness on individuals and their loved ones. Hence, the escalating number of cancer cases is stimulating the expansion of the neoantigen targeted therapies market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11944&type=smp
#What Long-Term Growth Rate is Expected for theNeoantigen Targeted Therapies Market Between 2025 and 2034?
The market size for neoantigen targeted therapies has experienced rapid expansion in the past few years. Expected to escalate from $3.4 billion in 2024 to $4.72 billion in 2025, it indicates a compound annual growth rate (CAGR) of 38.7%. The surge during the historical stretch is largely due to progress in genomic sequencing, the refinement of immunotherapy, increased comprehension of tumor immunology, the clinical effectiveness of checkpoint inhibitors, and advances in molecular profiling.
In the coming years, the market for neoantigen targeted therapies is projected to experience significant expansion, reaching $16.01 billion by 2029 with a compound annual growth rate (CAGR) of 35.7%. The anticipated growth within the forecasted period can be linked to advancements in the fields of bioinformatics, expansion of precision medicine, development of neoantigen vaccines, and strategies for therapeutic combination and biomarker validation. Key market trends to watch during this period include the management of neoantigen resistance, the adoption of neoantigen-primed cell therapies, the use of neoantigen-based combination therapies, the inclusion of real-world data, and improved predictive modeling.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11944
What New Market Trends Are Reshaping theNeoantigen Targeted Therapies Market and Its Opportunities?
Principal businesses in the neoantigen targeted therapies sector are using strategic alliances as a tool to personalize cancer treatments, thereby addressing the issues of current immunotherapy in handling solid tumors. Strategic alliances are a mechanism by which companies utilize each other’s unique abilities and assets to attain mutual advantages and prosperity. For example, BioNTech SE, a biotech firm based in Germany, formed a strategic alliance with the UK Government in January 2023 to enhance personalized mRNA cancer immunotherapies. The goal of this partnership is to provide customized therapies to approximately 10,000 patients by 2030, touching on key sectors like the development of cancer immunotherapies, research into vaccines for infectious diseases, and establishing a research and development center in Cambridge. The operation will tap into the UK’s infrastructure for clinical trials and health data resources to improve patient enlistment and select trial locations for BioNTech’s mRNA treatments. BioNTech plans to kick off its inaugural clinical trials in the UK later this year, with a focus on cancer vaccines that may potentially get incorporated into standard treatment procedures if found successful.
Who Are the Leading Market Players Fueling Growth in the Neoantigen Targeted Therapies Market Trend?
Major companies operating in the neoantigen targeted therapies market include F. Hoffmann-La Roche AG, Merck and Co. Inc., Bristol Myers Squibb Company, Eli Lilly and Company, Kite Pharma Inc., Gilead Sciences Inc., Amgen Inc., Moderna Inc., BioNTech SE, Bavarian Nordic Inc., Advaxis Inc., Immatics NV, Precision Biologics Inc., Iovance Biotherapeutics Inc., Agenus Inc., Achilles Therapeutics Plc, Medigene AG, Gritstone Bio Inc., SQZ Biotechnologies Company, Aduro BioTech Inc., Inovio Pharmaceuticals Inc., Gradalis Inc., EpiVax Inc., ISA Pharmaceuticals BV, Vaxon Biotech SA, Ziopharm Oncology, Genocea Biosciences Inc., Cellular Biomedicine Group Inc., Immunovaccine Inc.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/neoantigen-targeted-therapies-global-market-report
How is the Global Neoantigen Targeted Therapies Market Segemented?
The neoantigen targeted therapies market covered in this report is segmented –
1) By Type: Monotherapy, Combination Therapy
2) By Immunotherapy Type: DNA Or RNA-Based Vaccines, Protein-Based Vaccines, Dendritic Cell Vaccines, TIL-Based Therapies
3) By Target Disease Indication: Colorectal Cancer, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Bone Cancer, Gynecological Cancer
4) By Route Of Administration: Intradermal, Intravenous, Subcutaneous
5) By Application: Medical Research Institution, Hospital, And Clinic, Other Applications
Subsegments:
1) By Monotherapy: Individual Neoantigen-Targeted Treatments
2) By Combination Therapy: Neoantigen-Targeted Therapies Combined With Other Immunotherapies, Neoantigen-Targeted Therapies Combined With Chemotherapy, Neoantigen-Targeted Therapies Combined With Targeted Therapies
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=11944&type=smp
Which Geographics are Influencing the Growth of the Neoantigen Targeted Therapies Market?
North America was the largest region in the neoantigen targeted therapies market in 2024. The regions covered in the neoantigen targeted therapies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Gobal Neoantigen Targeted Therapies Maret 2025, By The Business Research Company:
Acute Myeloid Leukemia Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/acute-myeloid-leukemia-global-market-report
Cancer biologics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report
Point-of-Care Diagnostics Devices And Equipment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
